Programme 11 February
The programme is subject to changes.
09:15–10:20 | Norwegian life science strong points
Norwegian biotechnology for health preparedness in a European context
?
- Jan Christian Vestre, Minister of Health and Care Services
- Rino Rappuoli, leader European Vaccine Hub (EVH)
- Tore Godal, Doctor
- Bente Mikkelsen, Director Global Engagement Strategies, St.Jude Children's Research Hospital & Senior advisor Oslo Science City
- Cathrine Lofthus, Director General of Health and Chief Medical Officer Directorate of Health (chair)
AI instruments for better health
- Valeria Vitelli, Professor, University of Oslo
Precision medicine
- Kjetil Tasken, Head of Institute for Cancer Research Oslo University Hospital & Professor University of Oslo
10:20–11:00 | Life science frontiers
Embracing biological complexity to lead future innovation in healthcare and research
- John Quackenbush, Professor, T.H. Chan Harvard School of Public Health
Addressing Lifestyle Disorders with Gut Hormones
- Jens Juul Holst, Professor, University of Copenhagen
?
11:00–11:30 | Break
11:30–12:30 | Parallel Sessions: Norwegian life science strong points
AI instruments for better health
Producing algorithms that recommend, guide and perform.
Inclusive AI for Health: Designing technology that works for everyone
- Kristin Fuglerud, Chief Research Scientist, Norwegian Computing Center
AI-Driven Gene Prioritization for Complex Diseases: Accelerating the Discovery of Novel Therapeutic Targets
- Pooya Zakeri, Associate Professor, UiO
Artificial intelligence-guided point-of-care ultrasound in rural settings and in combat casualty care
- Cecilie V?penstad, Senior Research Scientist, SINTEF Digital
Foundation model for interactive segmentation of 3D medical images
- Arian Ranjbar, Group Leader, Akershus University Hospital
Chairs: Pooya Zakeri and Arian Ranjbar
Event organizer: TRUST – The Norwegian Centre for Trustworthy AI
One health
Antimicrobial resistance (AMR) risk management and systems theory applied to One Health challenges.
A systems-thinking framework for One Health research
- Lucy Robertson, Professor, NMBU
Antimicrobial resistance and One Health in a circular world
- Gunhild Hageskal, Senior Research Scientist, SINTEF
Strengthening access to priority antibiotics in a One-Health context – important for Norway, the Nordics, and Europe
- Christine ?rdal, Senior Scientist, Norwegian Institute of Public Health
Probiotics - the steep and rocky path to commercialization
- Henning S?rum, Entrepreneur and Professor, NMBU?
Chair: Finn-Arne Weltzien, Director Aquaculture Division, Nofima
Event organizer: SINTEF, Norwegian University of Life Sciences (NMBU) and Legemiddelindustrien (LMI)
Precision medicine ?
Emerging technologies and partnerships for precision diagnostics and treatment.
Genomic profiling of circulating tumor DNA for therapy selection in advanced cancer
- Ingrid Dyvik, Medical Doctor, Oslo University Hospital
Synthetic Killer Cells for Precision Immunotherapy
- Karl-Johan Malmberg, Group Leader, Oslo University Hospital
?
Using artificial intelligence for improved sepsis diagnostics
- Erik Sollig?rd, Professor & Deputy Director research, Norwegian University of Science and Technology
How can a private public collaboration with modern profiling on archived tumour-tissue increase the value of Norwegian health-data
- Steinar Thoresen, Medical Director and Co-Founder, Nordic RW
Chair: Jutta Heix, Head of International Affairs, Oslo Cancer Cluster
Event organizer: Oslo University Hospital, Oslo Cancer Cluster and LMI
11:30–12:45 | Young Talents Inspirational Talks
12:30–13:30 Lunch
13:30–15:30 | Afternoon Sessions
13:30–15:00 Young Talents Network Meetings
You will have the opportunity to meet representatives from companies.?
Note that you need to register for Network meetings in order to attend (same registration form).
Go to the programme
?
13:30–14:30 Health Data 2026?
This session will be held in Norwegian.
Using health data from hospitals for research and innovation in collaboration with industry.
Go to the programme
Organizer: LMI
14:30–15:30 The Life Science Building: New opportunities research-driven value creation through collaboration
This session will be held in Norwegian.
How can the new building provide new opportunities for research, education and innovation; serve as a resource for the region and Norway; and contribute to societal value creation?
Go to the programme
Organizer: UiO Growth House
13:30–13:40 Accelerating breakthrough innovations in healthcare
Toby Richardson?
Senior Director, External Scientific Innovation for Johnson & Johnson EMEA
13:45–15:00 Pitching Session
Join when startup companies and innovation projects pitch their business idea.
- Rab Diagnostics
Anette Weyergang, CEO - Eupnea
Sol Agnete Stene Aglen, Usability Engineer & Henriette Flesland Simonsen, Usability Engineer - Autologous cell-based therapy for coagulation factor deficiency
Giacomo Roman, Department of Haematology, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital - Possibia
Gaute Naespe, CEO - Development of engineered NK-EVs for Targeted Therapy in Breast Cancer
Marit Inngjerdingen, Dept. of Pharmacology, Institute of Clinical Medicine, University of Oslo - More startups to come
Panel:?
- Arnt-Ove Hovden, Therapeutical Area Lead Cardio, Renal and Metabolic diseases, AstraZeneca
- Maria Holmqvist, Medical Director Scandinavia, AbbVie
- ?ystein Bach, Marketing Director, Novartis
Host: Morten Egeberg, Leader SPARK Norway and Administrative Leader UiO:Life Science